Clinical Trial Update: Thoracic Re-irradiation For Locoregionally Recurrent Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating thoracic re-irradiation for locoregionally recurrent non-small cell lung cancer after prior thoracic radiotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Loco-regionally Recurrent NSCLC After Thoracic Radiotherapy | Phase 2 | Status: UNKNOWN